Skip to content

Released Mar 28, 2012, after the close

10-K filed Mar 28, 2012, 88 days after period end · 0001193125-12-137599

Q4 2011 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—
Net Income$1.59Mderivedno prior Q4 2010 on fileN/M vs Q3 2011
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived-$4,169,000N/M

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-K.

Same quarter

MetricQ4 2011derived from reported figuresQ4 2010derived from reported figures
Net Income$1.59M—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

SELLAS Life Sciences Group, Inc. · CIK 1390478 · Engraved from SEC EDGAR